Credit Agricole’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Sell
42,647
-44,742
-51% -$3.79M 0.01% 892
2026
Q1
$8.69M Buy
87,389
+170
+0.2% +$22.2K 0.02% 431
2025
Q4
$10.6M Buy
87,219
+23,604
+37% +$2.96M 0.02% 411
2025
Q3
$7.14M Buy
+63,615
New +$7.45M 0.02% 475
2025
Q1
$1.62M Buy
24,079
+12,929
+116% +$889K 0.01% 795
2024
Q4
$695K Buy
11,150
+8,955
+408% +$834K ﹤0.01% 1013
2024
Q3
$345K Buy
+2,195
New +$338K ﹤0.01% 1015

Other funds holding TMDX

Credit Agricole's TMDX Position: Q2 2026 in Review

Credit Agricole reduced its Transmedics (TMDX) stake by 51% in Q2 2026, selling an estimated $3.79M and leaving 42,647 shares worth $2.83M. The position accounts for 0.01% of the portfolio, ranked #892.

Credit Agricole first reported a position in TMDX in Q3 2024 and has held it in 7 quarters since. The position peaked at $10.6M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Credit Agricole held 42,647 shares of Transmedics worth $2.83M as of Q2 2026.
  • Credit Agricole sold 44,742 Transmedics shares in Q2 2026, an estimated $3.79M.
  • Transmedics made up 0.01% of Credit Agricole's portfolio in Q2 2026, its #892 holding.
  • Credit Agricole first reported a position in Transmedics in Q3 2024 and has held it in 7 quarters since.
  • Credit Agricole's Transmedics position peaked at $10.6M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.